Backgrounds/Aims: Various factors have been reported as prognostic factors of non-functional pancreatic neuroendocrine tumors (NF-pNETs). There remains some controversy as to the factors which might actually serve to successfully prognosticate future manifestation and diagnosis of NF-pNETs. As well, consensus regarding management strategy has never been achieved. The aim of this study is to further investigate potential prognostic factors using a large single-center cohort to help determine the management strategy of NF-pNETs. Methods: During the time period 1995 through 2013, 166 patients with NF-pNETs who underwent surgery in Samsung Medical Center were entered in a prospective database, and those factors thought to represent predictors of prognosis were tested in uni-and multivariate models. Results: The median follow-up time was 46.5 months; there was a maximum follow-up period of 217 months. The five-year overall survival and disease-free survival rates were 88.5% and 77.0%, respectively. The 2010 WHO classification was found to be the only prognostic factor which affects overall survival and disease-free survival in multivariate analysis. Also, pathologic tumor size and preoperative image tumor size correlated strongly with the WHO grades (p＜0.001, and p＜0.001). Conclusions: Our study demonstrates that 2010 WHO classification represents a valuable prognostic factor of NF-pNETs and tumor size on preoperative image correlated with WHO grade. In view of the foregoing, the preoperative image size is thought to represent a reasonable reference with regard to determination and development of treatment strategy of NF-pNETs. 
INTRODUCTION
Nonfunctioning pancreatic neuroendocrine tumors (NF-pNETs) are defined as pancreatic tumors of neuroendocrine origin without symptoms and secretion of symptom-related neuroendocrine peptide. Since they have no specific hormonal symptoms, the incidence of NF-pNETs is thought to be very low and while most are slow-growing, some with more aggressive biology may not present until they reach an advanced stage with a large mass, local invasion, and distant metastases. 1, 2 Previous studies have reported a high metastasis rate of NF-pNETs at initial detection ranging between 32% to 55%. But, with ongoing developments in imaging modalities over the last few decades, pancreatic neuroendocrine tumors (pNETs), particularly non-functioning ones, have been identified with increasingfrequency. 3 One population-based study showed that the incidence of small NF-pNETs (≤2 cm) has increased more than seven-fold over the last 22 years. 4 The NF-pNETs have a wide spectrum of clinical behaviors, ranging from those of benign nature with a favorable prognosis, to the more aggressive and highly malignant with extensive metastases. It has been suggested, in this particular context, that in the absence of evident signs of malignancy, typical pancreatic resections (i.e., pancreaticoduodenectomy and distal pancreatectomy) of NF-pNETs should be limited to the larger lesions. 5 Tumor size was advocated as a sentinel prognostic factor for its preoperative malignancy predictive value. Most neoplasms measuring ＜2 cm are likely benign or intermediate-risk lesions, and only 6% of NF-pNETs measuring ＜2 cm are malignant when incidentally discovered. 6 Any NF-pNET should be considered potentially malignant and treated accordingly. Surgery currently represents the preferred treatment for any localized pancreatic neoplasm, as surgical intervention corresponds to a significantly favorable survival benefit, even in cases of metastatic NF-pNETs. 7 However, with increasing detection of small NF-pNETs which is known to have excellent outcome, it is now a matter of debate as to whether all small and asymptomatic lesions should be routinely, automatically resected. 8 Currently, 2 cm is a widely used reference point in determining the need for more aggressive treatment. Some centers (prudently and exercising an abundance of caution), offer the option of an intensive imaging surveillance to patients who present with a high risk of morbidity or mortality for major pancreatic resection. There is, however, no long-term result documenting the successful (or less than successful) outcomes, or long-term therapeutic value, of surveillance as yet. Also, there is a lack of studies about any definite association between the imaging tumor size and other prognostic factors related to survival. Many retrospective analyses revealed the utility of prognostic factors of NF-pNETs, but differences of opinion persist. Moreover, no, consensus on management strategy has ever been achieved, and none exists at the present time.
We aimed to further investigate the prognostic factors using a large single-center cohort, and confirm the value of the imaging tumor size as a preoperative malignancy predictive factor to help determine the management strategy of NF-pNETs.
MATERIALS AND METHODS
The patient cohort was derived from the Samsung The recurrence and disease survival data was collected for prognostic stratification. 
RESULTS

Clinicopathological characteristics of 166 patients who underwent curative surgery
During the period January 1994 through December of 2013, 166 patients underwent surgical resection for NF-pNETs in Samsung Medical Center and the clinicopathologic characteristics of these patients are summarized in Table 1 which was lower than that of other recent SEER data, or European series. These findings are summarized in Table   1 .
The median pathologically measured tumor size was There were 24 patients (14.5%) with pathologically proven regional LN metastasis, and four patients (2.4%) with distant metastasis, which were all liver metastasis.
Radiofrequency ablation was performed in one case, and associated liver resection was performed in three cases of were G2, and 12 (7.2%) were G3, based on the 2010 WHO classification. These are summarized in Table 2 .
Prognostic factors of NF-pNETs
The median follow-up was 46.5 months with a maximum 217 months. The five-year overall survival and disease free survival rates were 88.5% and 77.0%, respectively. The prognostic factors affecting overall survival (OS) and disease-free survival (DFS) are listed in Pearson correlation coefficient of CT, MR, and EUS was 0.961, 0.903, and 0.913, respectively; and imaging size measured by CT has the most value, in terms of accuracy, with pathologic tumor size ( Table 6 ).
DISCUSSION
The malignant potential of NF-pNETs is difficult to predict, and the natural history of these tumors is not fully understood. In addition, the slow growth of NF-pNETs and the incomplete establishment of accurate prognostic factors makes the management of NF-pNETs even more problematic. So, there is no standard strategy for NF-pNETs in particular yet. Most studies advocate surgical resection as the only curative treatment for NF-pNETs of any size, as it has been traditionally believed that even small tumors can be malignant or metastasize to lymph nodes. 4, 13, 14 But, considering the risks of pancreatectomy is also important. Typical pancreatic resections are associated with a high incidence of perioperative complications such as pancreatic fistula, and exocrine and endocrine insufficiency. 15 Previous studies showed the incidence of new-onset diabetes after distal pancreatectomy as 9-36%. 16, 17 Therefore, ideally, the choice between close observation and surgical resection should be based on an accurate estimate of malignancy in these tumors. In this respect, identifying proper prognostic factors is imperative to for the purpose of establishing informed, practical and adequate treatment strategies for these patients. Observation may be even more acceptable for tumors less than 1 cm. And, we found evidence that some NF-pNETs show late recurrence. Seven patients of Grade 1 and one patient of Grade 2 suffered late recurrences after five years. Too, it is noteworthy that among these eight patients, five patients experienced recurrence after ten years.
It is thought that 4.8% of all patients experience late recurrence, therefore consideration of the possibility of recurrence and appropriate follow-up of surgically altered anatomy would strongly suggest that annual or biennial follow-ups, as well as follow-ups after five years, might be both medically advisable and medically justified.
There are limitations to this study. This data is retrospective and derived from a single institution and therefore might not be representative of any or all patient populations, given its relative diversity. To minimize the drawbacks caused by the retrospective nature of this study, we reviewed the pathologic grades and imaging studies with a dedicated pathologist and a radiologist.
Nevertheless and the constraints notwithstanding, it is felt that additional prospective studies on a multicenter or multinational level are needed to obtain prognostic factors of even greater weight in terms of substantial medical evidence.
In conclusion, given the significant morbidity associated with the surgical resection of NF-pNETs, the identification of preoperative variables that can be implemented to determine which patients would be best served by close observation and which patients would benefit from curative surgical resection, is both warranted and necessary. In our study, the WHO grade was found to be a highly significant prognostic factor of overall sur- 
